Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07100873
PHASE1

A Phase 1 Study of ADI-001 in Rheumatoid Arthritis

Sponsor: Adicet Therapeutics

View on ClinicalTrials.gov

Summary

ADI-001-106 is a phase 1 study of ADI-001 with a randomized, single-blind, parallel group design to compare two different LD regimens in subjects with treatment-refractory RA. The study will consist of different periods including screening, LD, treatment, and follow-up

Official title: A Phase 1 Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (γδ) T Cells in Adults With Treatment-refractory Rheumatoid Arthritis

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2025-10-10

Completion Date

2028-03-30

Last Updated

2025-12-08

Healthy Volunteers

No

Interventions

DRUG

ADI-001

Anti-CD20 CAR-T

DRUG

Fludarabine

Chemotherapy for Lymphodepletion

DRUG

Cyclophosphamide

Chemotherapy for Lymphodepletion

Locations (1)

Adicet Clinical Trials

Shanghai, Shanghai Municipality, China